This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Biopool U.S., Inc. dba Trinity Biotech Distribution, a foreign-owned for-profit manufacturer and distributor of clinical laboratory diagnostics and testing equipment. The 5-year, $4 million contract (Contract #36F79724D0149) is for Critical Analyzers, Laboratory equipment and supplies under FSS Group 66, Part III, with a period of performance from July 15, 2024 to July 14, 2029.
The contract primarily provides glycated hemoglobin (HbA1c) testing equipment, test kits, reagents, and associated laboratory supplies and support services to the VA. Specific items include the Premier HB9210 HPLC instrument for HbA1c analysis, with a FSS price of $5.03 per reportable result. The contract also allows for the procurement of other clinical diagnostic products such as syphilis and HIV test kits, glucose-6-phosphate dehydrogenase deficiency screening tools, and quality control items to support the VA's medical readiness and healthcare programs. Task orders under this IDV have ranged from $42 to $96,902.50, demonstrating the flexible, as-needed nature of the contracted services.
Generated 2/13/25, 9:04 AM